These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 35461153)

  • 1. Dravet syndrome in children-A population-based study.
    Bjurulf B; Reilly C; Sigurdsson GV; Thunström S; Kolbjer S; Hallböök T
    Epilepsy Res; 2022 May; 182():106922. PubMed ID: 35461153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining Dravet syndrome: An essential pre-requisite for precision medicine trials.
    Li W; Schneider AL; Scheffer IE
    Epilepsia; 2021 Sep; 62(9):2205-2217. PubMed ID: 34338318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of Dravet Syndrome in a US Population.
    Wu YW; Sullivan J; McDaniel SS; Meisler MH; Walsh EM; Li SX; Kuzniewicz MW
    Pediatrics; 2015 Nov; 136(5):e1310-5. PubMed ID: 26438699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes and comorbidities of SCN1A-related seizure disorders.
    de Lange IM; Gunning B; Sonsma ACM; van Gemert L; van Kempen M; Verbeek NE; Sinoo C; Nicolai J; Knoers NVAM; Koeleman BPC; Brilstra EH
    Epilepsy Behav; 2019 Jan; 90():252-259. PubMed ID: 30527252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of SCN1A-related dravet syndrome among children reported with seizures following vaccination: a population-based ten-year cohort study.
    Verbeek NE; van der Maas NA; Jansen FE; van Kempen MJ; Lindhout D; Brilstra EH
    PLoS One; 2013; 8(6):e65758. PubMed ID: 23762420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Life-span characterization of epilepsy and comorbidities in Dravet syndrome mice carrying a targeted deletion of exon 1 of the Scn1a gene.
    Gerbatin RR; Augusto J; Boutouil H; Reschke CR; Henshall DC
    Exp Neurol; 2022 Aug; 354():114090. PubMed ID: 35487274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The gain of function SCN1A disorder spectrum: novel epilepsy phenotypes and therapeutic implications.
    Brunklaus A; Brünger T; Feng T; Fons C; Lehikoinen A; Panagiotakaki E; Vintan MA; Symonds J; Andrew J; Arzimanoglou A; Delima S; Gallois J; Hanrahan D; Lesca G; MacLeod S; Marjanovic D; McTague A; Nuñez-Enamorado N; Perez-Palma E; Scott Perry M; Pysden K; Russ-Hall SJ; Scheffer IE; Sully K; Syrbe S; Vaher U; Velayutham M; Vogt J; Weiss S; Wirrell E; Zuberi SM; Lal D; Møller RS; Mantegazza M; Cestèle S
    Brain; 2022 Nov; 145(11):3816-3831. PubMed ID: 35696452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The incidence of SCN1A-related Dravet syndrome in Denmark is 1:22,000: a population-based study from 2004 to 2009.
    Bayat A; Hjalgrim H; Møller RS
    Epilepsia; 2015 Apr; 56(4):e36-9. PubMed ID: 25778844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of contraindicated medication use on cognitive outcome in Dravet syndrome and age at first afebrile seizure as a clinical predictor in SCN1A-related seizure phenotypes.
    de Lange IM; Gunning B; Sonsma ACM; van Gemert L; van Kempen M; Verbeek NE; Nicolai J; Knoers NVAM; Koeleman BPC; Brilstra EH
    Epilepsia; 2018 Jun; 59(6):1154-1165. PubMed ID: 29750338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dravet syndrome and Dravet syndrome-like phenotype: a systematic review of the SCN1A and PCDH19 variants.
    Rampazzo ACM; Dos Santos RRP; Maluf FA; Simm RF; Marson FAL; Ortega MM; de Aguiar PHP
    Neurogenetics; 2021 May; 22(2):105-115. PubMed ID: 33937968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe communication delays are independent of seizure burden and persist despite contemporary treatments in SCN1A+ Dravet syndrome: Insights from the ENVISION natural history study.
    Perry MS; Scheffer IE; Sullivan J; Brunklaus A; Boronat S; Wheless JW; Laux L; Patel AD; Roberts CM; Dlugos D; Holder D; Knupp KG; Lallas M; Phillips S; Segal E; Smeyers P; Lal D; Wirrell E; Zuberi S; Brünger T; Wojnaroski M; Maru B; O'Donnell P; Morton M; James E; Vila MC; Huang N; Gofshteyn JS; Rico S
    Epilepsia; 2024 Feb; 65(2):322-337. PubMed ID: 38049202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soticlestat, a novel cholesterol 24-hydroxylase inhibitor, reduces seizures and premature death in Dravet syndrome mice.
    Hawkins NA; Jurado M; Thaxton TT; Duarte SE; Barse L; Tatsukawa T; Yamakawa K; Nishi T; Kondo S; Miyamoto M; Abrahams BS; During MJ; Kearney JA
    Epilepsia; 2021 Nov; 62(11):2845-2857. PubMed ID: 34510432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gain of function SCN1A disease-causing variants: Expanding the phenotypic spectrum and functional studies guiding the choice of effective antiseizure medication.
    Matricardi S; Cestèle S; Trivisano M; Kassabian B; Leroudier N; Vittorini R; Nosadini M; Cesaroni E; Siliquini S; Marinaccio C; Longaretti F; Podestà B; Operto FF; Luisi C; Sartori S; Boniver C; Specchio N; Vigevano F; Marini C; Mantegazza M
    Epilepsia; 2023 May; 64(5):1331-1347. PubMed ID: 36636894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seizure precipitants in Dravet syndrome: What events and activities are specifically provocative compared with other epilepsies?
    Verbeek NE; Wassenaar M; van Campen JS; Sonsma A; Gunning B; Knoers N; Lindhout D; Jansen FE; Leijten F; Brilstra EH; Kasteleijn-Nolst Trenité D
    Epilepsy Behav; 2015 Jun; 47():39-44. PubMed ID: 26021464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SCN1A mutation spectrum in a cohort of Bulgarian patients with GEFS+ phenotype.
    Peycheva V; Ivanova N; Kamenarova K; Panova M; Pacheva I; Ivanov I; Bojidarova M; Tacheva G; Stamatov D; Litvinenko I; Hristova D; Deneva D; Rodopska E; Slavkova E; Aleksandrova I; Simeonov E; Dimova P; Bojinova V; Mitev V; Jordanova A; Kaneva R
    Turk J Pediatr; 2020; 62(5):711-725. PubMed ID: 33108073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation between clinical phenotypes and genotypes among 46 children with SCN1A-related developmental epileptic encephalopathy].
    Peng B; Zhu H; Tian Y; Li X; Wang X; Gao Y; Zhang Y; Shen H; Chen W
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2024 Apr; 41(4):426-431. PubMed ID: 38565507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of antiepileptic drugs for the treatment of Dravet syndrome with different genotypes.
    Shi XY; Tomonoh Y; Wang WZ; Ishii A; Higurashi N; Kurahashi H; Kaneko S; Hirose S;
    Brain Dev; 2016 Jan; 38(1):40-6. PubMed ID: 26183863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two autopsy cases of sudden unexpected death from Dravet syndrome with novel de novo SCN1A variants.
    Hata Y; Oku Y; Taneichi H; Tanaka T; Igarashi N; Niida Y; Nishida N
    Brain Dev; 2020 Feb; 42(2):171-178. PubMed ID: 31677916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel variant in SCN1A gene associated with Dravet syndrome.
    Pathirana B; Hettiarachchi D; Neththikumara NF; Ratnayake PD; Dissanayake V
    Seizure; 2019 Jul; 69():213-214. PubMed ID: 31102827
    [No Abstract]   [Full Text] [Related]  

  • 20. Epilepsy phenotype associated with a chromosome 2q24.3 deletion involving SCN1A: Migrating partial seizures of infancy or atypical Dravet syndrome?
    Lim BC; Hwang H; Kim H; Chae JH; Choi J; Kim KJ; Hwang YS; Yum MS; Ko TS
    Epilepsy Res; 2015 Jan; 109():34-9. PubMed ID: 25524840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.